Grants and Contributions:
Title:
In vitro and in vivo Studies of OB-002
Agreement Number:
978814
Agreement Value:
$252,953.00
Agreement Date:
May 3, 2021 - May 31, 2024
Description:
In vitro and in vivo studies will be conducted to further characterize
OB-002.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Ottawa, Ontario, CA K1S 1N4
Reference Number:
172-2021-2022-Q3-978814
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
708721493
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 92 days.
Amendment Date
Mar 12, 2024
Recipient's Legal Name:
Orion Biotechnology Canada Ltd.
Federal Riding Name:
Ottawa Centre
Federal Riding Number:
35075
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410
Amendments: